The University of Chicago Header Logo

Connection

Gladell P. Paner to Humans

This is a "connection" page, showing publications Gladell P. Paner has written about Humans.
Connection Strength

1.313
  1. Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance. Adv Anat Pathol. 2024 May 01; 31(3):157-168.
    View in: PubMed
    Score: 0.032
  2. Novel and Emerging Concepts in Genitourinary Tumors Empowered in the Multidisciplinary and Molecular Era. Adv Anat Pathol. 2024 May 01; 31(3):145-146.
    View in: PubMed
    Score: 0.032
  3. Glandular Lesions of the Urinary Bladder: Diagnostic and Molecular Updates. Adv Anat Pathol. 2024 Mar 01; 31(2):88-95.
    View in: PubMed
    Score: 0.032
  4. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas. Am J Surg Pathol. 2024 Jan 01; 48(1):e11-e23.
    View in: PubMed
    Score: 0.031
  5. Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists' Perspective. J Urol. 2023 07; 210(1):23-25.
    View in: PubMed
    Score: 0.030
  6. Updates in Grading of Renal Cell Carcinomas Beyond Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma. Adv Anat Pathol. 2022 May 01; 29(3):117-130.
    View in: PubMed
    Score: 0.028
  7. Flat intraurothelial lesions of the urinary bladder-do hyperplasia, dysplasia, and atypia of unknown significance need to exist as diagnostic entities? and how to handle in routine clinical practice. Mod Pathol. 2022 10; 35(10):1296-1305.
    View in: PubMed
    Score: 0.028
  8. Spectrum of biphasic renal cell carcinomas with hyalinized stroma and psammoma bodies associated and not associated with NF2 alteration. Hum Pathol. 2022 03; 121:11-18.
    View in: PubMed
    Score: 0.027
  9. Seminal vesicle cystadenoma with dysplasia: missing link to adenocarcinoma? Histopathology. 2021 08; 79(2):274-276.
    View in: PubMed
    Score: 0.027
  10. Mesonephric (Wolffian-derived) Adenocarcinoma of the Female Urethra. Am J Surg Pathol. 2021 04 01; 45(4):543-549.
    View in: PubMed
    Score: 0.026
  11. Morphological correlation of urinary bladder cancer molecular subtypes in radical cystectomies. Hum Pathol. 2020 12; 106:54-61.
    View in: PubMed
    Score: 0.025
  12. Potential biomarkers and risk assessment models to enhance the tumor-node-metastasis (TNM) staging classification of urologic cancers. Expert Rev Mol Diagn. 2020 09; 20(9):921-932.
    View in: PubMed
    Score: 0.025
  13. Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer. Cells. 2020 09 17; 9(9).
    View in: PubMed
    Score: 0.025
  14. Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79:82-104: Importance of Standardized Pathology Reporting for Urological Cancers in the Implementation of Urology Guidelines. Eur Urol. 2021 01; 79(1):e30-e32.
    View in: PubMed
    Score: 0.025
  15. Editorial Comment. J Urol. 2020 08; 204(2):265-266.
    View in: PubMed
    Score: 0.025
  16. Patterns of Urachal Remnant Involvement by Urothelial Carcinoma: Intraluminal Noninvasive Spread Can Mimic a Deep-seated Bladder Invasion. Am J Surg Pathol. 2019 04; 43(4):475-479.
    View in: PubMed
    Score: 0.023
  17. Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists. Arch Pathol Lab Med. 2019 05; 143(5):550-564.
    View in: PubMed
    Score: 0.023
  18. Plasmacytoid Urothelial Carcinoma: An Unusual Variant That Warrants Aggressive Management and Critical Distinction on Transurethral Resections. Arch Pathol Lab Med. 2019 12; 143(12):1562-1567.
    View in: PubMed
    Score: 0.023
  19. Contemporary Grading and Staging of Urothelial Neoplasms of the Urinary Bladder: New Concepts and Approaches to Challenging Scenarios. Surg Pathol Clin. 2018 Dec; 11(4):775-795.
    View in: PubMed
    Score: 0.022
  20. Reply to Vincenzo Di Nunno, Matteo Santoni, Alessia Cimadamore, Nicola Battelli, and Francesco Massari's Letter to the Editor re: Gladell P. Paner, Walter M. Stadler, Donna E. Hansel, et al. Updates in the Eight Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol 2018;73:560-9. Eur Urol. 2018 11; 74(5):e120-e121.
    View in: PubMed
    Score: 0.022
  21. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum. Virchows Arch. 2018 Jul; 473(1):85-93.
    View in: PubMed
    Score: 0.021
  22. Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers. Eur Urol. 2018 04; 73(4):560-569.
    View in: PubMed
    Score: 0.021
  23. Challenges in Pathologic Staging of Bladder Cancer: Proposals for Fresh Approaches of Assessing Pathologic Stage in Light of Recent Studies and Observations Pertaining to Bladder Histoanatomic Variances. Adv Anat Pathol. 2017 May; 24(3):113-127.
    View in: PubMed
    Score: 0.020
  24. Spectrum of Cystic Epithelial Tumors of the Prostate: Most Cystadenocarcinomas Are Ductal Type With Intracystic Papillary Pattern. Am J Surg Pathol. 2016 07; 40(7):886-95.
    View in: PubMed
    Score: 0.019
  25. Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin. Adv Anat Pathol. 2016 Mar; 23(2):71-83.
    View in: PubMed
    Score: 0.018
  26. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. Am J Surg Pathol. 2014 Sep; 38(9):1251-9.
    View in: PubMed
    Score: 0.017
  27. Immunohistochemical evaluation of novel and traditional markers associated with urothelial differentiation in a spectrum of variants of urothelial carcinoma of the urinary bladder. Hum Pathol. 2014 Jul; 45(7):1473-82.
    View in: PubMed
    Score: 0.016
  28. Clinicopathologic analysis of choriocarcinoma as a pure or predominant component of germ cell tumor of the testis. Am J Surg Pathol. 2014 Jan; 38(1):111-8.
    View in: PubMed
    Score: 0.016
  29. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Am J Surg Pathol. 2012 Mar; 36(3):432-42.
    View in: PubMed
    Score: 0.014
  30. Non-epithelial neoplasms of the prostate. Histopathology. 2012 Jan; 60(1):166-86.
    View in: PubMed
    Score: 0.014
  31. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Am J Surg Pathol. 2011 Jun; 35(6):787-98.
    View in: PubMed
    Score: 0.013
  32. Rete testis-associated nodular steroid cell nests: description of putative pluripotential testicular hilus steroid cells. Am J Surg Pathol. 2011 Apr; 35(4):505-11.
    View in: PubMed
    Score: 0.013
  33. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol. 2011 Jan; 18(1):79-89.
    View in: PubMed
    Score: 0.013
  34. A novel tumor grading scheme for chromophobe renal cell carcinoma: prognostic utility and comparison with Fuhrman nuclear grade. Am J Surg Pathol. 2010 Sep; 34(9):1233-40.
    View in: PubMed
    Score: 0.013
  35. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens. Am J Surg Pathol. 2010 Jun; 34(6):792-9.
    View in: PubMed
    Score: 0.012
  36. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2009 Jan; 33(1):91-8.
    View in: PubMed
    Score: 0.011
  37. Best practice in diagnostic immunohistochemistry: prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008 Sep; 132(9):1388-96.
    View in: PubMed
    Score: 0.011
  38. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma. Am J Surg Pathol. 2008 Jul; 32(7):1022-8.
    View in: PubMed
    Score: 0.011
  39. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2007 Sep; 31(9):1420-9.
    View in: PubMed
    Score: 0.010
  40. High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Arch Pathol Lab Med. 2007 Jan; 131(1):81-5.
    View in: PubMed
    Score: 0.010
  41. Accessible calculation of multirater kappa statistics for pathologists. Virchows Arch. 2006 Aug; 449(2):272.
    View in: PubMed
    Score: 0.009
  42. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney: significant immunophenotypic overlap warrants diagnostic caution. Am J Surg Pathol. 2006 Jan; 30(1):13-9.
    View in: PubMed
    Score: 0.009
  43. Passive seeding in metanephric adenoma: a review of pseudometastatic lesions in perinephric lymph nodes. Arch Pathol Lab Med. 2005 Oct; 129(10):1317-21.
    View in: PubMed
    Score: 0.009
  44. A retroperitoneal mass in an elderly woman. Pleomorphic rhabdomyosarcoma, classic variant, with reactive osteoclast-like giant cells. Arch Pathol Lab Med. 2005 May; 129(5):703-5.
    View in: PubMed
    Score: 0.009
  45. The Impact of Inherited Genetic Variation on DNA Methylation in Prostate Cancer and Benign Tissues of African American and European American Men. Cancer Epidemiol Biomarkers Prev. 2024 Apr 03; 33(4):557-566.
    View in: PubMed
    Score: 0.008
  46. NKX3.1 Expression in Non-Prostatic Tumors and Characterizing its Expression in Esophageal/Gastroesophageal Adenocarcinoma. Adv Anat Pathol. 2024 May 01; 31(3):202-205.
    View in: PubMed
    Score: 0.008
  47. Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves' disease). Endocr Pathol. 2004; 15(1):77-82.
    View in: PubMed
    Score: 0.008
  48. The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. J Natl Cancer Inst. 2023 11 08; 115(11):1364-1373.
    View in: PubMed
    Score: 0.008
  49. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leuk Lymphoma. 2003 Oct; 44(10):1811-4.
    View in: PubMed
    Score: 0.008
  50. Application of ChatGPT in Routine Diagnostic Pathology: Promises, Pitfalls, and Potential Future Directions. Adv Anat Pathol. 2024 Jan 01; 31(1):15-21.
    View in: PubMed
    Score: 0.008
  51. A single-institution review of the National Institutes of Health recommendation for prognostication of gastrointestinal stromal tumor. Hum Pathol. 2003 May; 34(5):512-3.
    View in: PubMed
    Score: 0.008
  52. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors. Anticancer Res. 2003 May-Jun; 23(3B):2253-60.
    View in: PubMed
    Score: 0.008
  53. Physician Perception of Grade Group 1 Prostate Cancer. Eur Urol Focus. 2023 11; 9(6):966-973.
    View in: PubMed
    Score: 0.008
  54. Pathologic quiz case: A cystic mass in the cerebellopontine angle. Arch Pathol Lab Med. 2003 Jan; 127(1):e45-6.
    View in: PubMed
    Score: 0.007
  55. Parafallopian tube transitional cell carcinoma. Gynecol Oncol. 2002 Sep; 86(3):379-83.
    View in: PubMed
    Score: 0.007
  56. Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue. Urology. 2022 12; 170:154-160.
    View in: PubMed
    Score: 0.007
  57. Pathologic quiz case: quadriplegic patient with recurrent paraspinal mass. Arch Pathol Lab Med. 2002 Aug; 126(8):987-8.
    View in: PubMed
    Score: 0.007
  58. Low-Grade Prostate Cancer: Time to Stop Calling It Cancer. J Clin Oncol. 2022 09 20; 40(27):3110-3114.
    View in: PubMed
    Score: 0.007
  59. Pathologic quiz case: incidental hepatic nodule on abdominal laparotomy. Arch Pathol Lab Med. 2002 Feb; 126(2):225-6.
    View in: PubMed
    Score: 0.007
  60. Histological validation of prostate tissue composition measurement using hybrid multi-dimensional MRI: agreement with pathologists' measures. Abdom Radiol (NY). 2022 02; 47(2):801-813.
    View in: PubMed
    Score: 0.007
  61. Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness. J Magn Reson Imaging. 2022 06; 55(6):1745-1758.
    View in: PubMed
    Score: 0.007
  62. Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy. Asian J Androl. 2021 Sep-Oct; 23(5):516-519.
    View in: PubMed
    Score: 0.007
  63. The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Adv Anat Pathol. 2021 Jul 01; 28(4):179-195.
    View in: PubMed
    Score: 0.007
  64. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol. 2021 07 01; 28(4):196-208.
    View in: PubMed
    Score: 0.007
  65. Should Grade Group 1 (GG1) be called cancer? World J Urol. 2022 Jan; 40(1):15-19.
    View in: PubMed
    Score: 0.006
  66. Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing Pathologists. Adv Anat Pathol. 2021 Jan; 28(1):1-7.
    View in: PubMed
    Score: 0.006
  67. College of American Pathologists Cancer Protocols: From Optimizing Cancer Patient Care to Facilitating Interoperable Reporting and Downstream Data Use. JCO Clin Cancer Inform. 2021 01; 5:47-55.
    View in: PubMed
    Score: 0.006
  68. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020 08; 44(8):e87-e99.
    View in: PubMed
    Score: 0.006
  69. Granular necrosis: a distinctive form of cell death in malignant tumours. Pathology. 2020 Aug; 52(5):507-514.
    View in: PubMed
    Score: 0.006
  70. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Am J Surg Pathol. 2020 05; 44(5):673-680.
    View in: PubMed
    Score: 0.006
  71. Hepatoid carcinoma of the pancreas. Cancer. 2000 Apr 01; 88(7):1582-9.
    View in: PubMed
    Score: 0.006
  72. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded. Pathology. 2020 Feb; 52(2):192-196.
    View in: PubMed
    Score: 0.006
  73. Mutational Profile Using Next-Generation Sequencing May Aid in the Diagnosis and Treatment of Urachal Adenocarcinoma. Int J Surg Pathol. 2020 Feb; 28(1):51-59.
    View in: PubMed
    Score: 0.006
  74. [Comparison of UICC and AJCC 8th edition TNM classifications in uropathology]. Ann Pathol. 2019 Apr; 39(2):158-166.
    View in: PubMed
    Score: 0.006
  75. Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder. World J Urol. 2019 Jan; 37(1):107-114.
    View in: PubMed
    Score: 0.005
  76. MEIS1 and MEIS2 Expression and Prostate Cancer Progression: A Role For HOXB13 Binding Partners in Metastatic Disease. Clin Cancer Res. 2018 08 01; 24(15):3668-3680.
    View in: PubMed
    Score: 0.005
  77. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. Am J Surg Pathol. 2018 03; 42(3):279-292.
    View in: PubMed
    Score: 0.005
  78. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy. Eur Urol Focus. 2019 05; 5(3):416-424.
    View in: PubMed
    Score: 0.005
  79. The New Realization About Cribriform Prostate Cancer. Adv Anat Pathol. 2018 Jan; 25(1):31-37.
    View in: PubMed
    Score: 0.005
  80. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer. Eur Urol Focus. 2019 05; 5(3):433-442.
    View in: PubMed
    Score: 0.005
  81. In reply to: letter to the editor entitled: primary pure lymphoepithelioma-like carcinoma of the ureter. Virchows Arch. 2017 10; 471(4):561-562.
    View in: PubMed
    Score: 0.005
  82. Lymphoepithelioma-like carcinoma of the upper urinary tract. Virchows Arch. 2017 Jun; 470(6):703-709.
    View in: PubMed
    Score: 0.005
  83. Prostate cancer detection following diagnosis of atypical small acinar proliferation. Can J Urol. 2017 Apr; 24(2):8714-8720.
    View in: PubMed
    Score: 0.005
  84. Influence of pathologist experience on positive surgical margins following radical prostatectomy. Urol Oncol. 2017 07; 35(7):461.e1-461.e6.
    View in: PubMed
    Score: 0.005
  85. Circulating tumor cells capture disease evolution in advanced prostate cancer. J Transl Med. 2017 02 23; 15(1):44.
    View in: PubMed
    Score: 0.005
  86. Iatrogenic changes in the urinary tract. Histopathology. 2017 Jan; 70(1):10-25.
    View in: PubMed
    Score: 0.005
  87. Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer. Eur Urol. 2017 09; 72(3):455-460.
    View in: PubMed
    Score: 0.005
  88. Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development. Stem Cells Dev. 2016 11 15; 25(22):1733-1741.
    View in: PubMed
    Score: 0.005
  89. Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy. Am J Surg Pathol. 2016 10; 40(10):1400-6.
    View in: PubMed
    Score: 0.005
  90. Risk of lymph node metastases in pathological gleason score=6 prostate adenocarcinoma: Analysis of institutional and population-based databases. Urol Oncol. 2017 01; 35(1):31.e1-31.e6.
    View in: PubMed
    Score: 0.005
  91. Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer. Cancer Immunol Res. 2016 07; 4(7):563-8.
    View in: PubMed
    Score: 0.005
  92. Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. Oncotarget. 2016 May 03; 7(18):26259-74.
    View in: PubMed
    Score: 0.005
  93. Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. Am J Surg Pathol. 2015 Oct; 39(10):1331-9.
    View in: PubMed
    Score: 0.004
  94. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World J Urol. 2016 May; 34(5):687-93.
    View in: PubMed
    Score: 0.004
  95. Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists. Am J Surg Pathol. 2015 Sep; 39(9):1242-9.
    View in: PubMed
    Score: 0.004
  96. Contemporary Population-Based Comparison of Localized Ductal Adenocarcinoma and High-Risk Acinar Adenocarcinoma of the Prostate. Urology. 2015 Oct; 86(4):777-82.
    View in: PubMed
    Score: 0.004
  97. Urinary bladder xanthoma: a multi-institutional series of 17 cases. Histopathology. 2015 Aug; 67(2):255-61.
    View in: PubMed
    Score: 0.004
  98. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Mod Pathol. 2015 May; 28(5):612-30.
    View in: PubMed
    Score: 0.004
  99. Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol. 2014 Jul; 38(7):871-4.
    View in: PubMed
    Score: 0.004
  100. Pathologic spectrum of cysts in end-stage kidneys: possible precursors to renal neoplasia. Hum Pathol. 2014 Jul; 45(7):1406-13.
    View in: PubMed
    Score: 0.004
  101. Uroplakin II outperforms uroplakin III in diagnostically challenging settings. Histopathology. 2014 Jul; 65(1):132-8.
    View in: PubMed
    Score: 0.004
  102. Influence of histologic criteria and confounding factors in staging equivocal cases for microscopic perivesical tissue invasion (pT3a): an interobserver study among genitourinary pathologists. Am J Surg Pathol. 2014 Feb; 38(2):167-75.
    View in: PubMed
    Score: 0.004
  103. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Am J Surg Pathol. 2013 Dec; 37(12):1876-81.
    View in: PubMed
    Score: 0.004
  104. Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence. Ann Diagn Pathol. 2014 Apr; 18(2):49-52.
    View in: PubMed
    Score: 0.004
  105. The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling. Hum Pathol. 2013 Aug; 44(8):1605-11.
    View in: PubMed
    Score: 0.004
  106. Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer. PLoS One. 2013; 8(1):e53701.
    View in: PubMed
    Score: 0.004
  107. Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases. Hum Pathol. 2013 May; 44(5):860-6.
    View in: PubMed
    Score: 0.004
  108. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma. J Urol. 2013 Jan; 189(1):53-8.
    View in: PubMed
    Score: 0.004
  109. ICUD-EAU International Consultation on Bladder Cancer 2012: Pathology. Eur Urol. 2013 Jan; 63(1):16-35.
    View in: PubMed
    Score: 0.004
  110. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol. 2013 Feb; 44(2):164-72.
    View in: PubMed
    Score: 0.004
  111. Predictors of Gleason Score (GS) upgrading on subsequent prostatectomy: a single Institution study in a cohort of patients with GS 6. Int J Clin Exp Pathol. 2012; 5(6):496-502.
    View in: PubMed
    Score: 0.004
  112. Deregulation of a Hox protein regulatory network spanning prostate cancer initiation and progression. Clin Cancer Res. 2012 Aug 15; 18(16):4291-302.
    View in: PubMed
    Score: 0.004
  113. Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula. Hum Pathol. 2011 Nov; 42(11):1770-6.
    View in: PubMed
    Score: 0.003
  114. Fyn is downstream of the HGF/MET signaling axis and affects cellular shape and tropism in PC3 cells. Clin Cancer Res. 2011 May 15; 17(10):3112-22.
    View in: PubMed
    Score: 0.003
  115. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol. 2010 Sep; 34(9):1367-76.
    View in: PubMed
    Score: 0.003
  116. Primary vascular tumors and tumor-like lesions of the kidney: a clinicopathologic analysis of 25 cases. Am J Surg Pathol. 2010 Jul; 34(7):942-9.
    View in: PubMed
    Score: 0.003
  117. Pseudomyxoma peritonei associated with primary mucinous borderline tumor of the renal pelvicalyceal system. Arch Pathol Lab Med. 2009 Sep; 133(9):1472-6.
    View in: PubMed
    Score: 0.003
  118. Comparison of open and robot-assisted pelvic lymphadenectomy for prostate cancer. J Endourol. 2009 Aug; 23(8):1313-7.
    View in: PubMed
    Score: 0.003
  119. Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009 Mar; 33(3):384-92.
    View in: PubMed
    Score: 0.003
  120. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol. 2009 Mar; 33(3):393-400.
    View in: PubMed
    Score: 0.003
  121. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg Pathol. 2009 Feb; 33(2):241-7.
    View in: PubMed
    Score: 0.003
  122. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009 Jan; 33(1):44-9.
    View in: PubMed
    Score: 0.003
  123. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am J Surg Pathol. 2009 Jan; 33(1):99-105.
    View in: PubMed
    Score: 0.003
  124. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base. Ann Diagn Pathol. 2009 Feb; 13(1):1-8.
    View in: PubMed
    Score: 0.003
  125. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008 Dec; 32(12):1822-34.
    View in: PubMed
    Score: 0.003
  126. Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) of the pancreas: second case report. J Gastrointest Surg. 2009 Apr; 13(4):806-9.
    View in: PubMed
    Score: 0.003
  127. Morphometric signature differences in nuclei of Gleason pattern 4 areas in Gleason 7 prostate cancer with differing primary grades on needle biopsy. J Urol. 2009 Jan; 181(1):88-93; discussion 93-4.
    View in: PubMed
    Score: 0.003
  128. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol. 2008 May; 15(3):127-39.
    View in: PubMed
    Score: 0.003
  129. Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Adv Anat Pathol. 2008 Jan; 15(1):28-38.
    View in: PubMed
    Score: 0.003
  130. Prognostic role of CD44 cell adhesion molecule expression in primary and metastatic renal cell carcinoma: a clinicopathologic study of 125 cases. Virchows Arch. 2008 Jan; 452(1):49-55.
    View in: PubMed
    Score: 0.003
  131. Identification of patients with low-risk for aneuploidy: comparative discriminatory models using linear and machine-learning classifiers in prostate cancer. Prostate. 2007 Oct 01; 67(14):1524-36.
    View in: PubMed
    Score: 0.003
  132. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications. Am J Surg Pathol. 2007 Oct; 31(10):1528-33.
    View in: PubMed
    Score: 0.003
  133. Morphometric sum optical density as a surrogate marker for ploidy status in prostate cancer: an analysis in 180 biopsies using logistic regression and binary recursive partitioning. Virchows Arch. 2006 Sep; 449(3):302-7.
    View in: PubMed
    Score: 0.002
  134. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. Am J Hematol. 2005 Jun; 79(2):97-106.
    View in: PubMed
    Score: 0.002
  135. Renal neoplasms in younger adults: analysis of 112 tumors from a single institution according to the new 2004 World Health Organization classification and 2002 American Joint Committee on Cancer Staging System. Arch Pathol Lab Med. 2005 Apr; 129(4):487-91.
    View in: PubMed
    Score: 0.002
  136. Sentinel node status and tumor characteristics: a study of 234 invasive breast carcinomas. Arch Pathol Lab Med. 2005 Jan; 129(1):82-4.
    View in: PubMed
    Score: 0.002
  137. Renal tumor with overlapping distal nephron morphology and karyotype. Arch Pathol Lab Med. 2004 Nov; 128(11):1274-8.
    View in: PubMed
    Score: 0.002
  138. Noninvasive carcinoma of the breast: angiogenesis and cell proliferation. Arch Pathol Lab Med. 2004 Aug; 128(8):893-6.
    View in: PubMed
    Score: 0.002
  139. Cytogenetic analysis of a series of 13 renal oncocytomas. J Urol. 2004 Feb; 171(2 Pt 1):602-4.
    View in: PubMed
    Score: 0.002
  140. Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances. Urology. 2002 Aug; 60(2):218-22.
    View in: PubMed
    Score: 0.002
  141. A carcinosarcoma/sarcomatoid carcinoma arising in a urinary bladder diverticulum. Arch Pathol Lab Med. 2002 Jul; 126(7):853-5.
    View in: PubMed
    Score: 0.002
  142. Serous microcystic adenoma of the pancreas. Arch Pathol Lab Med. 2001 Dec; 125(12):1613-4.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.